Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of prednisolone and dexamethasone: corticosteroids revisited
2019-004983-23Phase 4Active
- Sponsor
- University Medical Center Groningen
- Start
- Sep 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial comparing Prednisolone arm with Dexamethasone arm (2 arms). Primary endpoint: Bioequivalence via total cortisol suppression in 24-hour urine (low vs high dose prednisolone and dexamethasone). Started Sep 2020; status: active.
02
Drugs
prednisolonedexamethasone
Beyond the preview
Go deeper on 2019-004983-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004983-23.